Procurement Summary
Country: Ireland
Summary: Contract for the Provision for the Manufacture of Vaccine Antigen
Deadline: 16 Oct 2025
Posting Date: 27 Sep 2025
Other Information
Notice Type: Tender
TOT Ref.No.: 127148380
Document Ref. No.: 6637271
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
CPV Classification
33651600 - Vaccines
33600000 - Pharmaceutical products
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
UCD has developed a series of bacterial antigens which have proven effective in proof-of-concept studies and which the aim is to further develop and translate to humans. The lead target antigen is 22 kDa cytosolic bacterial protein and is currently His-tagged to facilitate affinity purification. UCD have developed a lab-scale expression and purification protocol, which will be provided to the successful contractor. We require contract protein manufacture and purification services. The purpose of the work is to appropriately scale-up the antigen to produce ~200mg batches of protein at a standard that will confirm feasibility of technology transfer and that can be used in GLP toxicology studies in mice, to ensure safety of the developed product. Ultimately, UCD would like the process to be amenable to production in a GMP facility in the future.
Procedure : Open
Publication Date : 16/10/2025
Deadline : 16/10/2025 00:00:00
Documents
Tender Notice